Background Whether four direct oral anticoagulants (DOACs) are superior to warfarin
among Asians with non-valvular atrial fibrillation (NVAF) remains unclear in the real-world …

Purpose: To systematically review available evidence of indirect comparisons from RCTs
and direct comparisons from observational studies regarding the comparative effectiveness …

Aims To analyse clinical outcomes with direct oral anticoagulants in patients with atrial
fibrillation according to geographic region. Methods We systematically searched MEDLINE …

Direct oral anticoagulants (DOACs) have increasingly replaced warfarin for treating patients
with non‐valvular atrial fibrillation (NVAF). DOACs have been demonstrated to be more …

Background There are no head-to-head randomized controlled trials comparing different
direct oral anticoagulants (DOACs). Thus, we systematically reviewed and meta-analyzed …

Background Much direct evidence has proved that the novel oral anticoagulants (NOACs)
are noninferior or superior to warfarin for stroke prevention in patients with nonvalvular atrial …

The presence of atrial fibrillation (AF), the most common sustained cardiac arrhythmia,
significantly increases the risk for stroke. Current guidelines recommend that the vitamin K …

We investigated the effectiveness and safety of direct oral anticoagulants (DOACs) for
secondary prevention in patients with atrial fibrillation (AF), particularly focusing on …

Background The development of novel oral anticoagulants (NOACs) has changed the
landscape of non-valvular atrial fibrillation (NVAF) management. In this study, the …

Background: To review data from the pivotal phase III trials evaluating the efficacy and safety
of direct oral anticoagulants (DOACs) versus warfarin for stroke prevention in patients with …